Small intestinal bacterial overgrowth and Helicobacter pylori: can they be cause of thrombocytopenia in patients with chronic liver disease?

MeSH terms

• Anti-Infective Agents / therapeutic use
• Chronic Disease
• Dose-Response Relationship, Drug
• Drug Administration Schedule
• Female
• Follow-Up Studies
• Helicobacter Infections* / complications
• Helicobacter Infections* / diagnosis
• Helicobacter Infections* / drug therapy
• Helicobacter pylori* / drug effects
• Helicobacter pylori* / growth & development
• Humans
• Intestine, Small / drug effects
• Intestine, Small / microbiology
• Liver Cirrhosis* / complications
• Liver Cirrhosis* / drug therapy
• Liver Cirrhosis* / pathology
• Male
• Randomized Controlled Trials as Topic
• Rifamycins* / therapeutic use
• Rifaximin
• Risk Assessment
• Thrombocytopenia* / etiology
• Thrombocytopenia* / physiopathology
• Treatment Outcome